Format

Send to

Choose Destination
J Pharmacol Pharmacother. 2012 Apr;3(2):196-9. doi: 10.4103/0976-500X.95532.

Ethionamide-induced gynecomastia.

Author information

1
Department of Respiratory Medicine, J. L. N. Medical College, Ajmer, India.

Abstract

Gynecomastia is very rare during antituberculosis chemotherapy. We describe a 38-year-old male patient who developed a painful gynecomastia following second-line drug therapy for multidrug-resistant pulmonary tuberculosis. Gynecomastia disappeared after stopping the ethionamide. A published literature on antituberculosis-induced gynecomastia is also briefly discussed.

KEYWORDS:

Antituberculosis therapy; drug-induced gynecomastia; ethionamide

Supplemental Content

Full text links

Icon for Medknow Publications and Media Pvt Ltd Icon for PubMed Central
Loading ...
Support Center